- Joined
- Sep 20, 2016
- Messages
- 1,802
- Reaction score
- 502
Why is Lyrica considered "clinically significant" in pain control for Fibro when the studies they are quoting show a difference of VAS from 6 to 5.6 after 14 weeks?
Seems odd that a 4% benefit in score allows at 700/month prescription with many side effects is somehow clinically acceptable?
How does that work?
Seems odd that a 4% benefit in score allows at 700/month prescription with many side effects is somehow clinically acceptable?
How does that work?